Statement: NIAID’s Statement on AstraZeneca’s Vaccine is Remarkable and Troubling
WASHINGTON, D.C. — Today, the National Institute of Allergy and Infectious Disease (NIAID) announced that the information released yesterday by AstraZeneca regarding its COVID-19 vaccine study may have relied on “outdated information from that trial, which may have provided an incomplete view of the efficacy data.” Michael Carome, director of Public Citizen’s Health Research Group released the following statement:
“This remarkable NIAID statement once again highlights the dangers of disseminating critical scientific information by company press release. There is no better way to undermine public confidence in a vaccine than for the manufacturer to make comments overstating the product’s effectiveness or safety and to then have to backtrack.”